Cite
MLA Citation
Cecile Vicier et al.. “TAKTIC: A prospective, multicentre, uncontrolled, phase IB/II study of LY2780301, a p70S6K/AKT inhibitor, in combination with weekly paclitaxel in HER2-negative advanced breast cancer patients.” European journal of cancer, vol. 159, 2021, pp. 205–214. http://access.bl.uk/ark:/81055/vdc_100146762475.0x000032